Tumor necrosis factor receptor-mediated signaling pathways.
about
MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinaseA Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosisPKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acidThe sphingolipid salvage pathway in ceramide metabolism and signalingDirect interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptorTumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activationPeptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2A surrogate-based approach for post-genomic partner identificationInhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signalingIdentification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implicationsChlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitroThe functions of cytokines and their uses in toxicologyConformational characterization of ceramides by nuclear magnetic resonance spectroscopy.Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD.Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.The study of the inhibition of the recombinant TACE prodomain to endotoxemia in mice.Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.Immune evasion by adenoviruses.The use of natalizumab for multiple sclerosisRole of TNF in lymphocyte-mediated cytotoxicity.Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives.Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome cInhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.Destination 'lysosome': a target organelle for tumour cell killing?Effects of sphingosine 2N- and 3O-methylation on palmitoyl ceramide properties in bilayer membranes.Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression.The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membraneThe adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes.Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors.The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disordersEpidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition.Sphingosine kinase signalling in immune cells.Ceramide: a signal for apoptosis or mitogenesis?Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusionCytokines in idiopathic inflammatory myopathies.Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanism.Role of Lipids in Brain Injury and Diseases.
P2860
Q24315104-584F439C-03E0-4ED6-84DD-86A0F759A393Q24564319-9921D1F1-1247-4EA6-AD38-A88D2156ED07Q24568285-A7E74A2D-8FCA-4DCD-8C3B-F556EA402DB6Q24642219-0D92E1C5-6876-43A1-B58A-28ACB6FF1C9DQ24653498-81143D8A-54D0-4569-AD63-07AE49B4F64DQ24679579-1D6A1349-F341-4FBE-9A69-56760B75D8FEQ24804955-DF40E82E-0E62-46DA-891B-A0F72A35AA5DQ24806189-768FEF2E-26EA-4C3A-B6AF-4C7349B941AFQ28140492-2B746363-3DB1-4EAD-A891-C29B169F0405Q28282373-AA9A33AA-E6A2-46F8-8E5C-BAB18708C020Q28378754-76D71C56-38ED-4C1B-8AF5-23F4E1226E18Q28385281-A735A7AB-54FE-48D1-9773-D857EC3729A0Q30682923-46E5CBD9-A2A9-4B88-A636-C91CE338B938Q33292436-4F0AABA5-CBE1-4E07-8C82-0ADEC092AAF6Q33507287-CC8038AE-F407-44ED-8C78-1E8413B9DC2CQ33572811-BFC4BBDF-E3F2-4F1D-93E6-FA6300B018A2Q33642411-C7382965-9AC8-40C9-A58D-C9A4915FA242Q33683353-388543CD-BDFE-4F2A-A01A-A4ED6772981DQ33879159-22D1AE2F-237E-4627-BEF8-78C8092F87BCQ33966313-520B5895-7B0C-43DD-BA3F-9A240DF4AD3EQ34316206-F96931E2-FE5A-40B4-9C95-4955857FC97CQ34457741-5757BECC-C0C6-4039-90FA-8CF122EF48BAQ35045007-99B721A9-9613-45F9-82FE-57C2127C4F7BQ35549436-C91FB3B4-664F-4AC7-B196-309B31844B64Q35627763-EB750EF4-4064-4D86-946F-78BEB1F88B34Q35752757-C80864E1-535A-452F-BC8D-EB6280C1AFA4Q35829148-30D86A56-4D69-4F69-A883-9B8EECCA0975Q35865485-D91C0C17-8689-4E0E-A75E-256B09BCD4CCQ35880562-983EEDE8-AFD9-489D-82E9-287CB4321FF4Q35884723-8C67521A-DC1E-4EE9-A1A8-6FB0F2309EE9Q35895541-2D0891E7-34F9-45CD-9C9C-486058E73996Q35915801-614A9FF8-1FD2-4A5B-9150-0128417D4C9EQ35925157-58D47705-FFCB-4F90-8FE9-F3D773DB1DB5Q36060030-8CB0BB81-F9F4-445C-93CB-25A691221839Q36364921-6FA809C4-2369-4655-9B1D-71F79229F57DQ36421633-890ECE88-0854-4C08-9337-92C5992C5EA0Q36504371-8B6E1A73-C304-4AA4-B685-DEBD6D43DD8FQ36573870-09E850AE-E204-42F1-8905-7833122744A9Q36846486-3DCAF355-35FC-4022-8C12-934415BCF1D2Q37051065-5F93624B-8BC6-4738-9D16-1DCC11FB3A6F
P2860
Tumor necrosis factor receptor-mediated signaling pathways.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Tumor necrosis factor receptor-mediated signaling pathways.
@en
type
label
Tumor necrosis factor receptor-mediated signaling pathways.
@en
prefLabel
Tumor necrosis factor receptor-mediated signaling pathways.
@en
P2860
P921
P356
P1476
Tumor necrosis factor receptor-mediated signaling pathways.
@en
P2093
P2860
P356
10.1083/JCB.126.1.5
P407
P577
1994-07-01T00:00:00Z